in E. coli; to adenine (Dalal et al., 1966) , to valine (Armstrong and Ishiwa, 1971) in Salmonella typhimurium;
and to uracil (Miller and Harrison,1950; Lacroute et al., 1965) in Saccharomyces cerevisiae. Although these nutrient-sensitive mutants are useful for studying cellular regulatory mechanisms, their isolation is not easy as compared with the isolation of auxotrophs because of the lack of suitable selective media and no detailed genetical analysis on any one of these nutrient sensitivity has been carried out.
Ishidsu isolated a new class of nutrient sensitive mutant in S. typhimurium (arginine sensitive) (1963) and devised a method for isolating mutants of this class (1967, 1973) . By the method, additional seven arginine sensitive mutants were isolated.
This made it possible to carry out genetical analysis of the arginine sensitivity in this organism.
This paper reports physiological characterization of arginine sensitive mutants isolated so far as a base of genetical and enzymological analyses on the arginine sensitivity, which will be reported elsewhere.
MATERIALS AND METHODS

Bacterial strains.
A wild strain LT2 of S, typhimurium was originated from the stock of Dr. M. Demerec. SJ1001 (ars-1) has been described by Ishidsu (1963 Ishidsu ( , 1973 . SJ1005 (ars-2) and SJ1007 (ars-3) (formerly arg-s-5 and arg-s-7, respectively) are sensitive only to arginine and 5J1002 (aus-1), SJ1003 (aus-2), SJ1004 (aus-3), SJ1006 (aus-4) and SJ1008 (aus-5) (formerly arg-s-2, arg-s-3, arg-s-4, arg-s-6 and arg-s-8, respectively) are sensitive to both arginine and uracil.
These seven mutants were isolated from LT2 by the method devised by Ishidsu (1967 Ishidsu ( , 1973 . SJ1064 (pyrA150) and SJ1217 (pyr-1020) were derived from LT2 (Yan and Demerec, 1965; Sanderson, 1972) . SJ1217 requires uracil or cytosine for growth.
Its mutation site lies not in A cistron but elsewhere. SJ1271 (argD21) was derived from LT2 and SJ2020 (arg-1012) was derived from a multiauxotrophic derivative SJ1926 (hisF6, gal-1001, trp-1571, bio-71) of LT2 (Sanderson, 1972) . They can grow in the presence of either arginine or citrulline, but not with ornithine. The mutation site of SJ1271 is considered to be in D cistron from the linkage relationship to other argD mutants (Demerec et al., 1960) ; that of SJ2020 is either in D or I (Sanderson, 1972; Syvanen and Roth, 1972) . Media and culture conditions. The minimal medium (SSA) was basically Medium A (Davis and Mingioli, 1950; Hartman, 1956 ) with slight modifications in the concentrations of glucose and citrate (Ishidsu, 1963) . Unless otherwise stated, the final concentrations of amino acids and nucleotide bases in the medium were 1 mM and those of vitamins 0.01 mM. Incubations were carried out at 37°C unless otherwise stated. Liquid cultures were contained in Erlenmeyer flasks. The volume of input medium was limited not to exceed 1/5 of the vessel's capacity. Inoculum size was 1/100 of the volume of media to be inoculated. Aeration was performed by shaking flasks at 70 to 130 strokes/min on a reciprocal shaker (Taiyo Incubator Model M-1).
RESULTS
Inhibition and recovery of growth by arginine and/or uracil. Growth of ars mutants was remarkably inhibited by arginine but not by uracil (Fig. 1) . That of aus mutants was inhibited by either arginine or uracil (Fig. 2) . Uracil removed the growth inhibition of ars mutants caused by arginine (Fig. 1) . Similarly, in aus mutants, if arginine and uracil were given simultaneously, all of them grew very well (Fig. 2) . In ars-1, the critical concentrations of arginine effective in growth inhibition were Cells were precultured in SSA with 1 mM arginine and 1 mM uracil and transferred to each medium after washing. Growth in SSA without any supplementation, 0; in SSA with 1 mM arginine, X ; with 1 mM uracil, p; with 1 mM arginine and 1 mM uracil, ®. between 0.01 and 0.1 mM (Ishidsu, 1963) . Between these two concentrations, arginine generated a prolonged lag before the mutant became free from the inhibition and started to grow at a similar rate to that in the absence of arginine (Fig. 3) . The length of the lag depended on the initial concentrations of arginine. Once growth started, however, it continued until a normal level of the stationary phase was attained, having no relation to the initial concentration of arginine. The majority of cells that survived after such a lag period and grew later were not revertants, since they again suffered from arginine inhibition upon transfer to fresh arginine medium (Fig. 4) . It was observed that the count of viable cells under arginine inhibition did not decrease for the first 10 hours (Ishidsu, 1964) , showing that the effect of arginine was not bacteriocidal but bacteriostatic (Fig. 3) . These phenomena suggest that arginine in the medium may be exhausted or inactivated during the lag period even without significant growth of the mutant cells, or that some system(s) which are effective in getting rid of the arginine inhibition may be induced after a certain duration, the length of which is controlled by the concentration of arginine. In aus mutants, the growth inhibition by uracil was a little less strict than that The growth patterns of aus-3 and aus-4 were similar to those of aus-2. All the aus mutants were `bradytrophic' (Novick and Mass, 1961) in regard to arginine and pyrimidine biosyntheses and this tendency was most extreme in aus-5.
Even in this mutant, however, the growth level attained after 20 hr incubation in minimal medium was significantly higher than that in the presence of arginine or uracil (Fig. 2) . Growth responses of ars-1 and aus-2 to arginine and uracil given together at various concentrations.
Although the growth of ars-1 in the presence of equimolar arginine and uracil was normal, limited concentrations of uracil with excess arginine caused a rapid cessation of growth at a certain 0. D, regardless of arginine concentration. This was more clearly elucidated from the observation (Fig. 5) that, when the concentration of uracil in a culture, started with 10 mM arginine and 0.01 mM uracil, was readjusted to 0.1 mM after the cessation of growth at the characteristic 0. D. of 0.01 mM uracil, the cells started to grow again logarithmically after a very short lag, but once again reached a stationary phase at the characteristic 0. D. level of 0.1 mM uracil. Such cessation of growth is the result of uracil exhaustion and, hence, the growth inhibition by arginine may reflect its inhibition of uracil biosynthesis.
Pyr-1020 and ars-1 were cultivated in SSA containing uracil at various concentrations, with the additional supplementation of 1 mM arginine for ars-1. Depending upon the original concentrations of uracil, the growth of ars-1, as well as of pyr-1020, suddenly ceased completely as soon as the 0. D. of the culture reached a certain level and there was a very fine correspondence between the two mutants with respect to the relationship between the original concentrations of uracil and the 0. D. at which growth ceased (Fig. 6) .
In a representative aus mutant, aus-2, the 0. D. at which growth stopped due to insufficient uracil was quite similar to that observed in ars-1.
However, in aus-2, arginine at a low concentration of 0.01 mM arrested the growth completely in the absence of uracil and, when 1/10 amount of arginine was supplemented simultaneously, the growth inhibition by uracil was completely removed at all concentrations of uracil tested.
The effect of uracil was exhibited only when arginine supplementation was less than 1/100 of the uracil supplementation.
This was in great contrast with the inhibitory effect of arginine, which was readily exhibited unless an equivalent or more amount of uracil was given together. It was also elucidated that uracil at a low concentration of 0.01 mM arrested the growth of aus-2 in the absence of arginine.
The difference between the effects of arginine and uracil observed above may be explained by either one of the following interpretations.
(i) Salmonella requires less arginine than uracil for full growth.
(ii) It has a more efficient transportation system for arginine than for uracil.
(iii) Uracil exhibits less efficiency to block the arginine biosynthesis when compared to that of arginine to block the uracil biosynthesis.
Since uracil at a low concentration of 0.01 mM arrested the growth of aus-2 in the absence of arginine as the same concentration of arginine did so in the absence of uracil, the third interpretation is less probable. The following observations provide a supporting evidence for the first or the second possibility.
Two arginine auxotrophs, argD21 and arg-1012, were cultivated in SSA containing arginine at various concentrations, with the excess supplementation of other requirements for arg-1012. These mutants were not of deletion type, but they were rather stable and only a few revertant colonies were found on minimal agar plates (with the supplementation of other requirements for arg-1012) seeded with about 2 x 108 cells. Only a decrease in the growth rate was observed after supposed arginine exhaustion.
In contrast with arginine which probably exerts its biological activities directly, uracil is generally converted to nucleotides in cells before it can be utilized as active biological factors, such as a nutritional element, a co-repressor or an inhibitor in feedback inhibition (Abd-El-AI and Ingraham, 1969a) . In compensating inhibitory effect of arginine in arginine sensitive mutants, the effective substance would be pyrimidine nucleotides, but not uracil itself. If this is true, the effective concentration of uracil may depend also on the efficiency of the system that converts uracil to nucleotides.
Effect of physiological conditions of cells on sensitivity to arginine. Growth of mutants either conditionally (ars-1) or essentially (pyr-1020) requiring uracil was immediately interrupted upon exhaustion of uracil. On the contrary, when arginine was added to a culture of ars-1 grown normally in minimal medium, or when cells were transferred from minimal medium to arginine medium, the growth interruption was not so strict and considerable residual growth was observed, especially at lower concentrations of arginine, or when such transfer was made during exponential growth (Fig. 3) . This means that, during the normal growth period, uracil itself or uracil synthesizing enzymes, or systems for forming such enzymes may be established and accumulated to a level sufficient to permit cells to grow residually after arginine addition. The observation that the growth rate became lower step by step by the repetition of dilutions and cultivations in fresh arginine medium (Fig. 4) also shows that whatever accumulated may be exhausted withoutjfurther synthesis after the addition of arginine.
However, if ars-1 was first grown in SSA supplemented with arginine and uracil and then transferred to arginine medium, the residual growth was neglected even when such transfer was made at mid-log phase (0. D. 0.56) (Fig. 7) . This mutant can grow in medium supplemented with arginine and uracil as well as, or even better than, in minimal medium, but the metabolic situations of cells under these two conditions should be quite different. The following conclusions are drawn from these observations. (i) Uracil, when supplied together with arginine, can support the growth of ars-1 but represses, at least to some extent, the uracil synthesizing system. Actually in ars-1, the formation of aspartate transcarbamylase, one of the enzymes in the uracil synthesizing system, was only 2.3% in the presence of 1 mM uracil and 1 mM arginine when compared with its formation in minimal medium (Ishidsu, unpublished data) . (ii) Cells first grown in medium containing both arginine and uracil suffer immediately from growth inhibition when transferred to arginine medium, since they lack an established uracil synthesizing system. (iii) Cells first grown in minimal medium do not suffer from immediate growth inhibition upon such transfer because of the establishment of Fig. 7 . Growth curves of ars-1 first grown in SSA containing 1 mM arginine and 1 mM uracil (I) and then transferred to the second media at various growth stages after washing (II). Growth in SSA without any supplementation, Q; in SSA with 1 mM arginine, p; with 1 mM arginine and 1 mM uracil,
•.
A broad arrow indicates the addition of concentrated uracil solution to the final concentration of 1 mM.
their uracil synthesizing system rather than because of accumulation of uracil itself. When ars-1 cells grown in the presence of arginine and uracil were transferred to fresh SSA supplemented only with uracil, 1 to 2 hr lag was generated before the cells resumed a logarithmical growth (Fig. 8) . This lag disappeared when the medium was additionally supplemented with citrulline as well as with arginine. Ornithine did not have this rescue effect.
This implies that ars-1 does not synthesize arginine in the presence of arginine, like the wild strain does not, and that this dependency of the mutant on arginine may be due to the block of the conversion of ornithine to citrulline by arginine.
The block at this specific step is supposed to be the result of the block of carbamyl phosphate formation which acts as a common substrate of ornithine and aspartate transcaxbamylases in this organism (Abd-El-AI and Ingraham, 1969a) . Growth inhibition and its removal by other chemicals.
Among chemicals examined so far, 19 essential amino acids (excluding arginine), common nucleotide bases or their derivatives (adenine, guanine, thymine and hypoxanthine) or some vitamins (pantothenate, thiamine, inositol, riboflavin, biotin and pyridoxine) scarcely affected the growth of ars-1 in SSA nor rescued cells from arginine inhibition, whether they were given separately or in combination.
Growth responses of ars-1 and aus-2 to various precursors in the arginine-pyrimidine biosynthetic pathways are summarized in Table 1 in comparison with those of Growth curves of ars-1 first grown in SSA containing 1 mM arginine and 1 mM uracil (I) and then transferred to various media at mid-log phase after washing (II). Growth in SSA without any supplementation, 0; in SSA with 1 mM arginine, x; with 1 mM uracil, Q; with 1 mM arginine and 1 mM uracil, e.
pyrA150.
In contrast to ars-1, the growth of aus-2 was severely inhibited by citrulline.
The fact that citrulline removed, but ornithine did not, the inhibition by uracil clearly shows that the dependency of aus-2 on arginine in the presence of uracil may be due to the block of the arginine pathway by uracil at the transcarbamylation step. Ureidosuccinate and dihydroorotate allowed the mutants to grow slightly around their crystals placed on plates containing arginine.
However, these compounds showed no significant effect at a high concentration of 1 mM in liquid media. This is explained as the result of their poor permeation into cells (O'Donovan and Neuhard, 1970) . A peculiar phenomenon observed with aus-2 was the stimulation of growth by ornithine in the presence of ureidosuccinate or dihydroorotate. Ornithine is known to act as a stimulator of caxbamyl phosphate synthetase (Pierard, 1966; AbdEl-Al and Ingraham, 1969a) , but it did not stimulate the bradytrophic growth of aus-2 in minimal medium when given alone.
Growth of some pyrimidine mutants in Neurospora crassa (Broadbent and Charles, 1965 ) and E. coli (Charles and Roberts, 1968) which require both arginine and uracil in air is known to be stimulated by CO2 on minimal medium.
On the growth of ars-1, however, 30 or even 50% (v/v) CO2 in gas phase showed no effect at all.
It has been reported in many systems that some analogues of amino acids or nucleotide bases were effectively used to select mutants that had some alteration in the corresponding genetical regulatory systems (Shepherdson and Pardee, 1960; Maas, 1961; Sheppard, 1964; Roth et al., 1966) . With the hope that ays or aus mutants might react differently from the wild strain, some analogues of arginine, or substances structurally resembling to it, were screened for their effect on ays-1 by an auxanographic method.
Tested were norvaline, urea, nitrourea, phenylurea, thiourea, phenylthiourea, guanidine hydrochloride, nitroguanidine, nitrosoguanidine, 1, 3-diphenylguanidine, dicyanodiamide and dicyanodiamidine sulfate. None of these chemicals could discriminate the arginine sensitive strain from the insensitive one.
Effect of incubation temperature. Abd-El-AI and Ingraham (1969b) reported that a mutation in the pyrA locus exhibited a cold sensitive phenotype requiring arginine for growth at 20°C but not at 37°C. Growth responses of ays-1 at various temperatures between 25°C and 42°C were studied.
Figures 9a and 9b show growth curves in minimal and in 1 mM arginine medium, respectively.
In minimal medium, the growth of derepressed cells of ars-1 was a little slower at all temperatures than that of the wild type. In arginine medium, the extent of arginine inhibition of derepressed cells was greater at higher temperatures.
In repressed cells, the inhibition was complete and no significant difference was observed among the growth at various temperatures employed.
The growth of the wild type was scarcely affected by the presence of arginine at the temperatures tested. It was concluded that the arginine sensitivity of ars-1 was temperature sensitive in the sense that repression of uracil biosynthesis or inhibition of some enzyme(s) involved (probably carbamyl phosphate synthetase), or both, by arginine took place more effectively at higher temperatures.
The affinity of arginine for the substance concerned may increase as incubation temperature raises. During the course of these experiments, it was noticed at 42°C that both the mutant and the wild strains were sensitive to 10 mM uracil and that this inhibitory effect was antagonized by arginine slightly. This uracil effect was not so apparent at 40°C and not observed at 37°C.
DISCUSSION
The present experiments indicated that the arginine sensitivity of ays mutants was caused by a shortage of uracil.
The site of mutation in ays-1 was found to be closely linked to the pyrA locus (Eisenstark, 1967) . The pyrA gene was reported to be the structural gene for carbamyl phosphate synthetase (Yan and Demerec, 1965) . PyrAmutants lacked the activity of this enzyme (Pierard and Wiame, 1964) . Similarly, ars-1 has only about 2.6% activity of this enzyme in the wild strain even when cells were grown in minimal medium (Abd-El-AI and Ingraham,1969b) .
These findings show that the effect of arginine on the mutant was to block carbamyl phosphate synthesis. In aus mutants, arginine and uracil compensated the inhibitory effect of each other, implying contrariwise that they inhibited the biosynthesis of each other. It was clearly shown by nutritional experiments with arginine precursors that the growth inhibition by uracil was caused by a blockage of transcarbamylation of ornithine to citrulline (Table 1) . As has been briefly reported (Ishidsu, 1969) , mutational sites of all the aus mutants were closely linked to the pyrA locus, which mapped apart from the argl gene, the structural gene for ornithine transcarbamylase (Syvanen and Roth, 1972; Sanderson, 1972) . Then the aus type mutation also seems to have a direct effect on carbamyl phosphate synthesis.
It has been found that there were two independent enzymatic syntheses of carbamyl phosphate in Neurospora (Reissig, 1960 (Reissig, , 1963 Charles, 1962; Davis, 1962) and in yeast (Lacroute et al., 1965) , one specific for the arginine pathway and the other for the pyrimidine pathway.
When there is a channelling of carbamyl phosphate as in Neurospora (Davis and Woodward, 1962; Davis, 1963 Davis, , 1967 , mutants lacking the enzymatic activity of either one of the two carbamyl phosphate syntheses turn out to be auxotrophic for either arginine or pyrimidine and no arginine nor uracil sensitivity is exhibited.
However, if there is no such channelling as in yeast (Lacroute et al., 1965) , mutants blocked in the arginine specific carbamyl phosphate synthesis become uracil sensitive, but do not become arginine auxotrophs, since the activity of the uracil specific carbamyl phosphate synthetase is subject to feedback inhibition by uridine 5'-triphasphate and there is no carbamyl phophate available for arginine synthesis in the presence of uracil. Similarly, mutational blockage in the uracil specific carbamyl phosphate synthesis causes arginine sensitivity. This is a unique example that a mutation in a structural gene at the sites governing the catalytic activity of the enzyme codedd by the gene results in nutrient sensitivity.
On the contrary, in E. coli or S. typhimurium, the occurrence of one-step, singlesite mutants simultaneously auxotrophic for arginine and uracil (Roepke cited in Tatum, 1946; Yan and Demerec, 1965) and the localization of all such mutants within the same small genetic region (pyrA) (Beckwith et al., 1962; Pierard et al., 1965; Yan and Demerec, 1965) show the existence of a single enzymatic system synthesizing carbamyl phosphate for both pathways.
This system is subject to partial but cumulative repression by arginine and/or uracil and to feedback control by uridine 5'-monophosphate (UMP) Abd-El-AI and Ingraham, 1969a) . Uracil sensitive mutants so far found in E, coli have been mapped in the pyrA locus and the mechanism of their occurrence has been interpreted as an increased sensitivity of the carbamyl phosphate synthetase to feedback inhibition by UMP ). As mentioned above (Table 1, Fig. 8 ), the effect of arginine on arginine sensitive mutants was considered also to block carbamyl phosphate synthesis.
However, it has not been reported that the carbamyl phosphate synthetase itself from wild strains of E. coli or S. typhimurium exhibited any direct affinity for arginine, though its activity was enhanced by an arginine precursor, ornithine (Pierard, 1966; Abd-El-AI and Ingraham, 1969a) . This makes it difficult to interpret the precise mechanism of the arginine sensitivity, contrary to the case of uracil sensitivity described above. A possibility that these mutations lie in a regulator gene closely linked to pyrA and make the carbamyl phosphate synthesizing system completely repressible by arginine or uracil alone, rather than by arginine plus uracil as in the wild type, cannot be ruled out for the present. 
SUMMARY
